The Association of the British Pharmaceutical Industry (ABPI) released Guidance Notes on the Management of Adverse Events and Product Complaints from Pharmaceutical Company Sponsored Websites this week. The guidance provides suggested best practices for monitoring and managing adverse events and product complaints from social media use of company-sponsored websites. It addresses ways pharmaceutical companies may learn of adverse events through social media, suggests that companies should declare their involvement and responsibility for the website, and recommends that company-owned sites provide access to “internal/external reporting based tools which allow users to report suspected adverse drug reactions.”
Read more: